CMAC is a world-class international hub for manufacturing research and training. Working in partnership with industry, its purpose is to transform current manufacturing processes into the medicine supply chain of the future.
Find out moreCMAC’s vision is to revolutionise the way pharmaceuticals and high value products are made. The approaches developed and adopted within CMAC have been developed through close collaboration with industry and the support of its Tier 1 partners, which includes GlaxoSmithKline, AstraZeneca, Bayer, Lilly, Novartis, Pfizer, Roche and Takeda. Established in 2011, the CMAC has a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, and more than 30 PhD students, as well as an experienced support team.
Industrially relevant research delivered by a multidisciplinary and collaborative academic team
Find out more
Comprehensive suite of continuous processing, process analysis, and characterisation equipment housed in the Technology and Innovation Centre at Strathclyde
Find out more
A vibrant world-class, multi-disciplinary PhD & MSc training programmes that will equip graduates with leading edge skills in pioneering continuous processes
Find out more
The demand-led manufacturing research scope of the Centre was co-created with our industry partners
Find out morePhD Vacancy: Plant-wide dynamic mathematical modelling and optimisation of integrated continuous pharmaceutical manufacturing processes
PhD Vacancy: Plant-wide dynamic mathematical modelling and optimisation of integrated continuous pharmaceutical manufacturing processes.... more
Automated Synthesis Forum
At TIC, University of Strathclyde.... more
Continuous Flow Reactor Technology for Industrial Applications
Hosted in TIC, University of Strathclyde.... more
CMAC Future Manufacturing Research Hub Operations during COVID-19
In response to the Covid-19 outbreak and following advice from the WHO, the UK and Scottish Governments, the University of Strathclyde has taken the decision to restrict highly populated areas in the interest of student and staff safety. Therefore CMAC has closed all laboratory and office areas..... more
New Industry Director joins CMAC
We are delighted to announce the appointment of Massimo Bresciani as CMAC’s new Industry Director from the 3rd February 2020..... more
MMIC to Develop Platform for Quicker Optimization of OSD Formulations
Partnership between CPI, University of Strathclyde, GSK and AstraZeneca to utilize continuous manufacturing process. MMIC Grand Challenge 1 underway with CMAC at University of Strathclyde..... more